e-learning
resources
Paris 2018
Monday, 17.09.2018
Granulomatous disorders: heterogeneous diseases with variable management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Exhaled Breath Biomarkers in Sarcoidosis: A Systematic Review
D. Terrington (Norwich, United Kingdom), C. Hayton (Manchester, United Kingdom), A. Peel (Norwich, United Kingdom), S. Fowler (Manchester, United Kingdom), A. Wilson (Norwich, United Kingdom)
Source:
International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
Session:
Granulomatous disorders: heterogeneous diseases with variable management
Session type:
Thematic Poster
Number:
3003
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Terrington (Norwich, United Kingdom), C. Hayton (Manchester, United Kingdom), A. Peel (Norwich, United Kingdom), S. Fowler (Manchester, United Kingdom), A. Wilson (Norwich, United Kingdom). Exhaled Breath Biomarkers in Sarcoidosis: A Systematic Review. 3003
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Breath Biomarkers in Idiopathic Pulmonary Fibrosis: A Systematic Review
Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Year: 2018
Correlation between Blood Eosinophilia and Fractional Exhaled Nitric Oxide in the diagnosis of Asthma within Primary Care.
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020
Systematic Review and Meta-Analysis of Endoscopic Lung Volume Reduction Using Endobronchial Valves in Severe Emphysema: Are They Better?
Source: International Congress 2018 – General thoracic surgery
Year: 2018
Does Exhaled Nitric Oxide Correlate with Established Measures of Asthma Severity?
Source: International Congress 2018 – Biomarkers for evaluating asthma
Year: 2018
Prognostic Significance of Hematologic Biomarkers in Small Cell Lung Cancer: a Meta Analysis and Systematic Review
Source: International Congress 2019 – Biology of lung cancer
Year: 2019
Late Breaking Abstract - Metabolomics in Exhaled Breath Condensate (EBC) of asthmatic patients. Does severity and methodology make the difference?
Source: International Congress 2017 – Late-breaking findings in asthma and COPD
Year: 2017
Differential expression of miRNAs in Exhaled Breath Condensate (EBC) and EBUS-TBNA of patients with Mediastinal Tuberculosis and Pulmonary Sarcoidosis
Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases
Year: 2020
Exhaled Breath Analysis for Prediction of Response to Anti-PD1 Therapy in Patients with NSCLC
Source: International Congress 2017 – Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies
Year: 2017
Cardiac MRI for Prognosis in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis
Source: Virtual Congress 2020 – Imaging-based phenotyping in pulmonary disease
Year: 2020
ATS/ERS Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide
Source: Guideline 2005
Year: 2005
Exhaled Volatile Organic Compounds are Able to Diagnose Systemic Sclerosis
Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
Exhaled breath condensate pH in assessment of childhood asthma control
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014
Exhaled Breath Analysis for the Diagnosis of Obstructive Sleep Apnea
Source: International Congress 2018 – Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality
Year: 2018
Can Exhaled Nitric Oxide Be a Biomarker for Hospitalized and Post-COVID-19 Patients?
Source: Virtual Congress 2021 – Biological and functional markers of COVID-19
Year: 2021
Book Review: Pulmonary Hypertension
Source: Eur Respir Rev 2012 21: 372
Year: 2012
MCC-IMS Analyses of Volatile Markers from Exhaled Air for Detection of Bacterial Infection between nasal suction and exhalation through Mouth
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019
Normal values of exhaled nitric oxide at 50 mL/s – A revisit
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Aerobic and Breathing Exercises Improve Dyspnea, Exercise Capacity and Quality of Life in Idiopathic Pulmonary Fibrosis Patients: Systematic Review and Meta-Analysis.
Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia
Year: 2019
Exhaled nitric oxide in asthma: Relationship with breath gymnastic and FeNO levels
Source: International Congress 2015 – Paediatric asthma and allergy: lung function and biomarkers
Year: 2015
Comparison of Fractional Nitric Oxide in Exhaled Breath in bronchial asthma and COPD
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept